Panacea Acquisition Corp
SEC CIK 1811063 · PANA · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mashal Robert | Director | filed 2024 - 2026 |
| Falberg Kathryn E | Director | filed 2021 - 2026 |
| Blickenstaff KIM D | Director | filed 2021 - 2026 |
| Vernon W Anthony | Director | filed 2021 - 2026 |
| Cui Xiangmin | Director | filed 2024 - 2026 |
| Bazemore Robert B | Director | filed 2021 - 2026 |
| Hung David | Director · President and CEO | filed 2021 - 2026 |
| Wang Junyuan Jerry | Director · CEO, ANHEART THERAPEUTICS LTD. | filed 2024 - 2024 |
| Welch Daniel G | Director | filed 2021 - 2024 |
| Nodelman Oleg | Director · CEO and Chairman of the Board | filed 2020 - 2023 |
| Ecor1 Capital Fund, L.P. | Director | filed 2020 - 2023 |
| Ecor1 Capital, LLC | Director | filed 2020 - 2023 |
| Ecor1 Capital Fund Qualified, L.P. | Director | filed 2020 - 2023 |
| Ecor1 Venture Opportunity Fund, LP | Director | filed 2020 - 2023 |
| Biotech Opportunity GP, LLC | Director | filed 2020 - 2023 |
| Ecor1 Panacea Holdings, LLC | Director | filed 2020 - 2021 |
| Bradbury Daniel | Director | filed 2020 - 2021 |
| Hasnain Faheem | Director | filed 2020 - 2021 |
| Sharp Shalini | Director | filed 2020 - 2021 |
| Cooper Graham K | Director | filed 2020 - 2021 |
| Doig Michelle | Director | filed 2021 - 2021 |
| Marriott Sarah | Director · Secretary | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wentworth Kerry | Chief Regulatory Officer | filed 2022 - 2026 |
| Markel Stacy | SVP, Human Resources | filed 2021 - 2026 |
| Sauvage Philippe | Chief Financial Officer | filed 2024 - 2026 |
| Liu Dongfang | Chief Medical Officer | filed 2022 - 2026 |
| Hattersley Gary | Chief Scientific Officer | filed 2021 - 2026 |
| Hanley David C. | Chief Technical Operations | filed 2021 - 2026 |
| Makunje Moses | See Remarks | filed 2023 - 2026 |
| Sjogren Colleen | Chief Commercial Officer | filed 2024 - 2026 |
| Fox Jennifer A. | Chief Financial Officer | filed 2021 - 2023 |
| Templeman Thomas | SVP, Pharmaceutical Ops | filed 2021 - 2021 |
| Yurasov Sergey | Chief Medical Officer | filed 2021 - 2021 |
| Perlen Scott | Chief Financial Officer | filed 2020 - 2020 |
| Stout Caroline | Chief Investment Officer | filed 2020 - 2020 |
| Platshon Scott | Chief Operating Officer | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.